Jazz Pharmaceuticals plc ($JAZZ)
Filing Information
| Accession Number | 0001783908-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
20
Total Shares
167,679
Total Value
$17,139,182.29
P&L
+inf% (+$1,837,653.67)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 20,125 | $113.10 | $2,276,137.50 | 73,464 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 16,602 | $192.53 | $3,196,334.91 | 56,862 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 875 | $113.10 | $98,962.50 | 57,737 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 875 | $192.07 | $168,056.96 | 56,862 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 27,084 | $137.12 | $3,713,758.08 | 83,946 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 15,555 | $190.28 | $2,959,806.96 | 68,391 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 2,916 | $137.12 | $399,841.92 | 71,307 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 2,916 | $189.81 | $553,490.92 | 68,391 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Grant/Award | 10,079 | $0.00 | $0.00 | 78,470 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 11,529 | $191.65 | $2,209,480.97 | 66,941 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 3,523 | $193.58 | $681,993.26 | 63,418 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 1,061 | $190.00 | $201,593.71 | 62,357 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 549 | $190.80 | $104,747.17 | 61,808 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 1,784 | $191.88 | $342,311.96 | 60,024 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 1,009 | $192.79 | $194,526.62 | 59,015 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Ordinary Shares | โ | Feb 26, 2026 | Sale | 197 | $193.60 | $38,138.85 | 58,818 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Incentive Stock Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 875 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Incentive Stock Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 2,916 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Non-Qualified Stock Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 20,125 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP & Chief Legal Officer | Non-Qualified Stock Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 27,084 | $0.00 | $0.00 | 0 | Direct | โ | View Details |